3D Global Biotech (ROCO:6808) Debt-to-Asset : 0.03 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Debt-to-Asset?

3D Global Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$6.30 Mil. 3D Global Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$4.08 Mil. 3D Global Biotech's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was NT$324.15 Mil. 3D Global Biotech's debt to asset for the quarter that ended in Dec. 2023 was 0.03.

3D Global Biotech Debt-to-Asset Historical Data

The historical data trend for 3D Global Biotech's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Debt-to-Asset Chart

3D Global Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.01

0.04

0.05

0.03

3D Global Biotech Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial							0.05	0.05	0.05	0.04	0.03

Competitive Comparison of 3D Global Biotech's Debt-to-Asset

For the Biotechnology subindustry, 3D Global Biotech's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Global Biotech's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's Debt-to-Asset falls into.

3D Global Biotech Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

3D Global Biotech's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(6.297	+	4.082)	/	324.148
	=	0.03

3D Global Biotech's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(6.297	+	4.082)	/	324.148
	=	0.03

3D Global Biotech (ROCO:6808) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

3D Global Biotech Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech (ROCO:6808) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Rd, 21st Floor -3, Xizhi District, New Taipei, TWN, 221

Website

http://www.3dglobalbiotech.com.tw

3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech (ROCO:6808) Headlines

No Headlines